Kraig Biocraft Laboratories Announces Investor Web Conference Highlighting Commercialization Progress of Spider Silk Technologies
Kraig Biocraft Laboratories (OTCQB: KBLB) announced an investor web conference scheduled for December 4, 2024, at 4:30 pm ET. The conference will showcase the company's achievements in commercializing spider silk fibers over the past year. CEO Kim Thompson highlighted record-setting progress in scaling up spider silk production and developing next-generation super fibers. The presentation will be available on the company's website and YouTube channel, covering business model progress and upcoming targets.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha annunciato una conferenza web per investitori programmata per il 4 dicembre 2024, alle 16:30 ET. La conferenza metterà in evidenza i risultati raggiunti dall'azienda nella commercializzazione delle fibre di seta di ragno nell'ultimo anno. Il CEO Kim Thompson ha sottolineato progressi senza precedenti nell'aumento della produzione di seta di ragno e nello sviluppo di fibre super innovative di nuova generazione. La presentazione sarà disponibile sul sito web dell'azienda e sul canale YouTube, coprendo i progressi del modello di business e i prossimi obiettivi.
Kraig Biocraft Laboratories (OTCQB: KBLB) anunció una conferencia web para inversores programada para el 4 de diciembre de 2024, a las 4:30 p.m. ET. La conferencia destacará los logros de la empresa en la comercialización de fibras de seda de araña durante el último año. El CEO Kim Thompson enfatizó el progreso récord en la ampliación de la producción de seda de araña y el desarrollo de super fibras de próxima generación. La presentación estará disponible en el sitio web de la empresa y en su canal de YouTube, cubriendo los avances del modelo de negocio y los objetivos futuros.
Kraig Biocraft Laboratories (OTCQB: KBLB)는 2024년 12월 4일 오후 4:30 ET로 예정된 투자자 웹 회의를 발표했습니다. 이 회의에서는 지난 한 해 동안 거미 실크 섬유 상용화에서 회사의 성과를 보여줄 것입니다. CEO 킴 톰프슨은 거미 실크 생산의 대규모 확장과 차세대 슈퍼 섬유 개발에서 기록적인 발전을 강조했습니다. 발표는 회사의 웹사이트와 유튜브 채널에서 이용 가능하며, 비즈니스 모델의 진행 상황과 향후 목표를 다룰 것입니다.
Kraig Biocraft Laboratories (OTCQB: KBLB) a annoncé une conférence web pour les investisseurs prévue pour le 4 décembre 2024 à 16h30 ET. La conférence mettra en avant les réalisations de l'entreprise dans la commercialisation des fibres de soie d'araignée au cours de l'année écoulée. Le PDG Kim Thompson a souligné les progrès records réalisés dans l'extension de la production de soie d'araignée et le développement de super fibres de nouvelle génération. La présentation sera disponible sur le site web de l'entreprise et sur sa chaîne YouTube, couvrant l'avancement du modèle commercial et les objectifs à venir.
Kraig Biocraft Laboratories (OTCQB: KBLB) hat eine Investoren-Webkonferenz angekündigt, die für den 4. Dezember 2024 um 16:30 Uhr ET geplant ist. Die Konferenz wird die Erfolge des Unternehmens bei der Kommerzialisierung von Spinnenseidefasern im vergangenen Jahr präsentieren. CEO Kim Thompson hob die rekordverdächtigen Fortschritte bei der Skalierung der Spinnenseidenproduktion und der Entwicklung von Superfasern der nächsten Generation hervor. Die Präsentation wird auf der Website des Unternehmens und dem YouTube-Kanal verfügbar sein und die Fortschritte des Geschäftsmodells sowie kommende Ziele abdecken.
- Record-setting progress in scaling up spider silk production
- Advancement in commercialization of spider silk technologies
- Development of next-generation super fibers
- None.
ANN ARBOR, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), the leading developer of spider silk-based fibers, today announced it will be publishing its investor web conference on December 4, at 4:30 pm ET. This conference provides an in-depth review of the Company's amazing progress over the past twelve months in commercializing its revolutionary spider silk fibers.
"This has been an amazing year for Kraig Labs and for commercial scale production of recombinant spider silk for the textile markets. I am excited to share the record-setting progress Kraig Labs made this year in scaling up our spider silk production and in the development of the next generation of super fibers," said Company Founder and CEO, Kim Thompson. "This shareholder conference will highlight the substantial business model progress we have made this year, as well as some of our upcoming targets and goals."
Interested viewers will be able to find the video at www.kraiglabs.com/videos or through the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270 starting on December 4, at 4:30 pm ET.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
FAQ
When is Kraig Biocraft Laboratories (KBLB) hosting its investor web conference?
Where can investors watch KBLB's December 2024 web conference?
What will be discussed in KBLB's December 2024 investor conference?
